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Summary
Both pathogenic and non-pathogenic mycobacteria
are internalized into macrophage phagosomes.
Whereas the non-pathogenic types are invariably
killed by all macrophages, the pathogens generally
survive and grow. Here, we addressed the survival,
production of nitrogen intermediates (RNI) and intra-
cellular trafficking of the non-pathogenic Mycobac-
terium smegmatis, the pathogen-like, BCG and the
pathogenic M. bovis in different mouse, human and
bovine macrophages. The bacteriocidal effects of RNI
were restricted for all bacterial species to the early
stages of infection. EM analysis showed clearly that all
the mycobacteria remained within phagosomes even
at late times of infection. The fraction of BCG and
M. bovis found in mature phagolysosomes rarely
exceeded 10% of total, irrespective of whether bacteria
were growing, latent or being killed, with little correla-
tion between the extent of phagosome maturation and
the degree of killing. Theoretical modelling of our data
identified two different potential sets of explanations
that are consistent with our results. The model we
favour is one in which a small but significant fraction of
BCG is killed in an early phagosome, then maturation
of a small fraction of phagosomes with both live and
killed bacteria, followed by extremely rapid killing and
digestion of the bacteria in phago-lysosomes.
Introduction
Infection with mycobacteria remains a major health
problem. Although in the recent years infections by
M. avium are gaining importance among imunosup-
pressed individuals, tuberculosis is still the major problem.
Mycobacteria from Mycobacterium tuberculosis complex,
M. africannum, M. bovis and M. tuberculosis, are the
aetiological agents of this disease (Wedlock et al., 2002;
Baker et al., 2006). In many countries, M. bovis is respon-
sible for important economic losses due to bovine tuber-
culosis (Pollock and Neill, 2002; Biet et al., 2005). This
Mycobacterium can also infect humans, causing tubercu-
losis, with a pathobiology indistinguishable from that one
caused by M. tuberculosis (Hedvalle, 1949; Wedlock
et al., 2002). The success of these pathogens is, to a
large part, dependent on their ability to inhibit host
defence mechanisms and persist in a potentially hostile
environment, the macrophage phagosome, and is also
facilitated by the emergence of multidrug-resistant strains
and extensively drug-resistant strains (Gandhi et al.,
2006).
The crucial difference between non-pathogenic and
pathogenic mycobacteria is that the latter arrest maturation
of phagosomes at an early stage (Clemens, 1996; Via
et al., 1998; Vergne et al., 2004; Stewart et al., 2005).
Although the mechanism responsible for this process is
poorly understood, the arrested phagosome provides a
friendly environment for pathogen survival and even
growth (Hart et al., 1972; Russell, 2001; Pethe et al.,
2004). The mycobacterial phagosome has particular char-
acteristics such as low content of vacuolar ATPase
(V-ATPase) (Sturgill-Koszycki et al., 1994), and thereby
incomplete luminal acidification, as well as a low content of
mature lysosomal enzymes. Collectively these pathogen-
altered conditions are assumed to facilitate survival of the
mycobacteria (Russell, 2001; Vergne et al., 2004).
The question of how and where mycobacteria are killed
by macrophages is still open, for both the non-pathogenic
and pathogenic forms (Kusner, 2005). From the literature
two extreme models can be envisaged. In the first, the
killing only occurs after phagolysosome fusion; in this
model, the macrophage-killing potential depends on its
abilty to fuse the phagosome with late endocytic
organelles, here, often simplified as ‘lysosomes’. Thereby,
it is presumed that the combination of low pH and a
battery of lysosomal hydrolases induces both killing and
digestion/clearance of the bacteria. In agreement with this
hypothesis are extensive data correlating a high incidence
of phagolysosomal fusion with a high rate of killing, and a
low extent of this fusion with high survival (Silva et al.,
1987; Russell, 2001; Kusner, 2005). This model is widely
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favoured and is also supported by an early study by Cohn
(1963a,b), who first showed that lysosomal extracts are
potentially bacteriocidal; that study showed that extracts
of macrophage or neutrophil lysosomes can induce killing
of E. coli within 1 min. In the case of M. smegmatis in
J774 cells, a rapid 1–4 h killing period coincides with
extensive phagolysosome fusion, and the internalization
of a cocktail of lysosomal enzyme inhibitors by endo-
cytosis into infected macrophages strongly reduced the
potency of this early killing period Anes et al. (2006).
An alternative hypothesis emerged from the pioneering
study by Armstrong and D’Arcy Hart (1971). Based on a
thorough EM analysis in which endocytosed ferritin was
used as a lysosomal marker, these authors came to the
conclusion that the live M. tuberculosis actively avoided
phagolysosome fusion, a point that is widely appreciated.
Less appreciated is their conclusion that only after being
killed in a non-matured phagosome could the phagosome
fuse with lysosomes. In contrast, when M. tuberculosis
opsonized with a specific anti-M. tuberculosis antibody
before internalization, the majority of the bacterial
phagosomes now fused with lysosomes. However,
M. tuberculosis nevertheless multiplied at the same rate
as the non-opsonized bacteria, that were predominantly in
non-mature phagosomes (Hart et al., 1972). A similar con-
clusion was made later by Gomes et al. (1999). In these
experiments, the accumulation of pathogenic mycobacte-
ria in a mature phagolysosome (that also contained Cox-
iella burnetii) did not induce killing of M. tuberculosis or
M. avium. More recently, elegant assays were used to
select for M. tuberculosis mutants that can survive in
mature phagosomes (Pethe et al., 2004; MacGurn and
Cox, 2007; Majlessi et al., 2007). All these observations
are clearly at odds with the model in which mycobacteria
are killed in mature phagosomes.
Nitric oxide (NO) produced from iNOS is a more well-
defined component of host defence against intracellular
pathogens, including M. tuberculosis (Shiloh and Nathan,
2000). Phagocytes produce NO and a plethora of other
potent mycobacteriocidal reactive nitrogen intermediates
following stimulation with mycobacteria, and this process
is accentuated by inflammatory cytokines like g-IFN
and/or bacterial lipopolysaccharides (LPS) (Chan et al.,
2001; Webb et al., 2001; Morris et al., 2003). The toler-
ance of mycobacteria in vitro to RNI is strain-, dose- and
time-dependent, with the pathogens being inherently
more resistant than the non-pathogens (O’Brien et al.,
1994; Rhoades and Orme, 1997; Long et al., 1999; Long
et al., 2005). In our recent study of the non-pathogenic
M. smegmatis, the macrophage needs at least 4 h, and
up to 24–48 h after infection to completely kill the bacteria.
Nevertheless, the expression of iNOS and the production
of NO, which facilitated bacterial killing, was restricted to
the first 2 h (Anes et al., 2006).
Most published studies have compared up to two
different cell types and two different mycobacteria, often
with different virulence, such as M. tuberculosis H37Ra
and Rv. We decided to make a broader analysis of
mycobacterial–macrophage interactions. The main goal
was to try to find a pattern of killing or survival that
could be clearly correlated with macrophage-killing
mechanisms. Towards this goal, after preliminary studies
with M. smegmatis, we tested different mycobacteria
(M. bovis and M. bovis BCG) in up to six different cell
types: mouse [bone marrow macrophages (BMM), J774
and Raw], human [monocyte-derived macrophages from
human peripheral blood (HMDM) and THP1] and bovine
macrophages (monocyte-derived macrophages from
bovine peripheral blood: BMDM). For M. bovis spp. we
first monitored intracellular survival following colony-
forming units (cfu) and then investigated the role of NO.
Subsequently, different assays for phagolysosome fusion
and acidification were applied.
Our results suggest that a specific pathogen-induced
macrophage ‘program’ is induced upon infection that
correlates with the bacterial doubling time, in which
phases of high macrophage-killing potential often alter-
nate with phases conducive to bacterial growth. RNI and
low pH play key roles in killing during the first day(s) of
infection of pathogenic mycobacteria. Subsequently,
RNI- and pH-independent mechanisms kill the bacteria
within phagosomes. Our results, in conjunction with
theoretical modelling for BCG infection, argue that a
significant killing of these mycobacteria must occur in
non-matured, early phagosomes, in agreement with
Armstrong and D’Arcy Hart (1971). However, the major-
ity of BCG is more likely to be killed and digested after
phagolysosome formation.
Results
Kinetics of M. smegmatis survival in different
host macrophages
From previous studies, M. smegmatis infecting J774 are
killed completely within 48 h under all infection conditions
(Kuehnel et al., 2001; Anes et al., 2003; Anes et al.,
2006). M. smegmatis survival kinetics inside J774 is
complex and was characterized in detail previously (Anes
et al., 2006). A striking observation was a dynamic inter-
play between bacteria and J774 cells (Fig. 1A). A first
phase of killing (4 h) was followed by growth (4–8/9 h) and
subsequent killing phases between 9 and 48 h.
Here we used GFP-expressing M. smegmatis and fol-
lowed the cfu in BMM derived from C57BL/6 mice and in
HMDM. In BMM, the dynamics of M. smegmatis showed a
super-imposable pattern to that seen in J774 macro-
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(Fig. 1B), the initial killing phase was seen but, thereafter,
different kinetics were observed, with the remaining
M. smegmatis being killed slowly in a continuous fashion.
For HMDM, the same pattern of killing by 4 h was also
seen at higher levels of infection (results not shown). It is
striking, and surely no coincidence, that in all four cell
types, the first killing period is found between 1 and 4 h
and, when growth is permitted, it peaks in both cells
around 8 h. These data suggest that the timing of these
cycles is likely to be induced by the bacteria that divide
every 3 h.
Kinetics of M. bovis spp. survival in different
host macrophages
The above data suggested that the cycles of killing and
growth might be induced by factors related to the cell
cycle of the pathogen. This idea made it interesting to
investigate pathogenic mycobacteria, which have a far
longer division time (around 24 h) than M. smegmatis. We
therefore tested BCG and M. bovis in six different cell
lines: J774, Raw, BMM, the human monocytic like cell line
THP1, HMDM and BMDM (Fig. 2A–F). We first estab-
lished infection conditions for BCG-GFP in J774. This
GFP strain grows at identical rates, in vitro and in mac-
rophages, to the parental non-GFP strain (results not
shown). Bacteria were added at OD600 0.1 for 3 h; this
gave on average 2–9 bacteria per cell. For the other cells,
the same conditions were used, except for HMDM and
BMDM, in which case OD600 0.1 appeared to be toxic for
the cells. We therefore used an OD600 of 0.01, which
allowed the cells to survive normally for at least 7 days. In
all our reported experiments, the total number of live
macrophages remained almost constant over the period
of infection, as assessed by cell counts.
Using the trypan blue exclusion method, less than 1%
macrophage death was detected under all conditions.
Thus, in this study macrophage cell death could be
excluded as having any significant role in the killing of
mycobacteria.
As shown in Fig. 2A–F, we saw three different patterns
of bacterial survival. In BMM, THP1 and J774, an overall
pattern of killing was observed over the 7 day period. With
Raw, neither significant growth nor killing was observed.
In contrast, in HMDM, BCG grew up to 3 days, and there-
after, neither growth nor killing was seen. We initially used
time scales of hours for these experiments, but it soon
emerged that the switches from killing to growth, when
they occurred, happened on a much slower time scale
with the pathogenic mycobacteria, in agreement with the
hypothesis that timing of the macrophage cycles of killing
and growth is related to the bacterial growth/division time.
We next compared BCG with the virulent strain of
M. bovis in J774 and HMDM. In J774, whereas BCG
could be steadily killed over the course of 7 days infection
(Fig. 2G), M. bovis could be killed only during the first 24 h
that was following a growth phase; this is more easily
observed using a linear scale (Fig. 2G1) rather than the
semilog scale used in Fig. 2G. With HMDM, both BCG
and M. bovis could steadily grow at a level easily seen on
Fig. 1. Intracellular fate of M. smegmatis in
different macrophages. Colony-forming unit
(cfu) estimates for M. smegmatis (GFP) are
shown in J774 macrophages (A), Raw
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a semilog scale (Fig. 2H). Thus, both bacteria behave
quite differently in the two macrophage cell types and are
better adapted to survive and grow exponentially in the
human primary macrophages.
It is difficult to visualize any meaningful trends in these
data, although some cells (THP1 and BMM) tended
towards a similar gradual killing of BCG. There was no
obvious ranking of macrophage ‘killer cells’ when we com-
pared their abilities to kill M. smegmatis, BCG or M. bovis.
For example, J774 kills BCG better than Raw, but Raw is
much more effective than J774 cells in clearing
M. smegmatis.
Role of inducible NO synthase and NO release
We next related the pattern of intracellular growth/killing to
the pattern of macrophage activation that is known to
contribute to killing of mycobacteria. We first investigated
NO production using the Griess reagent. In our recent
study on M. smegmatis, in J774 cells we showed that NO
is only produced up to 2 h after infection, where it contrib-
uted to the first killing phase (Anes et al., 2006). Here we
focused on BCG and M. bovis.
First, we tested the susceptibilities of different myco-
bacteria to NO in vitro. For these, we used two NO
Fig. 2. Intracellular fate of BCG (GFP) or M. bovis in different host macrophages. Colony-forming unit (cfu) estimates for BCG (GFP) in J774
macrophages (A), Raw macrophages (B), BMM (C), HMDM (D), THP1 cells (E) and BMDM (F). A comparison between the cfu estimates
































4 L. Jordao et al.
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology
sources NOC-18 (Fig. 3A and B) and acidic solutions of
sodium nitrite (not shown). BCG could be killed by 0.1 mM
NOC18 after 1 day, but after 14 days in culture, a 100-fold
higher concentration of NOC-18 was needed for efficient
killing (Fig. 3A). In contrast, M. bovis was highly resistant;
after 1 day in culture, only partial killing was seen with
1 mM NOC-18 (a 10-fold higher concentration than that
needed to kill BCG) and, to achieve complete killing, a
1000-fold higher concentration of NOC-18 was required
(Fig. 3B).
We next investigated cell production of NO in response
to BCG and M. bovis. NO was not detected in superna-
tants of HMDM under any conditions, in agreement with
other studies on human macrophages (Clemens and
Horwitz, 1995). g-IFN is known to induce strong iNOS
activity and often also an increase in mycobacterial killing
(Nozaki et al., 1997; Bonecini-Almeida et al., 1998;
Carpenter et al., 1998; Schaible et al., 1999). As seen in
Table 1, overnight treatment of J774 cells with g-IFN
before infection led to a highly significant increase in NO
levels after 1 and 2 day infection with BCG or M. bovis.
We next tested the effects of NO on M. bovis spp.
survival in J774. For this, we either increased NO artifi-
cially, using NOC-18 or g-IFN, or decreased NO levels by
blocking the enzyme (iNOS) that synthesizes it, with a
specific inhibitor: L-NAME. At 1 day post infection, 0.1 or
1 mM NOC-18 was able to significantly increase the killing
of BCG and M. bovis (around 40% increase in killing)
respectively (Fig. 3C and D). The extent of killing by
NOC-18 and g-IFN was similar for M. bovis, whereas
g-IFN had a small but insignificant effect on BCG survival
at day 1 (Fig. 3C and D). With L-NAME, a reproducible
and significant (30 and 40%) increase in survival was
observed after 1 day infection of BCG- and M. bovis-
infected macrophages (Fig. 3C and D). After 1 day,
neither NOC-18 nor L-NAME affected mycobacterial sur-
vival (results not shown). Taking in account the limit of
quantification of NO using the Griess method, we
observed low but detectable amounts of NO production
during the early infection periods with both strains
(Table 1: 3 h and 1 day post infection).
Figure 3E and F shows the effects of an extended treat-
ment of infected cells with g-IFN, until 7 day infection.
These results show clearly that, for BCG, g-IFN treatment
modestly but significantly increases bacterial killing until
day 3, with little effect thereafter (Fig. 3E). With M. bovis
(Fig. 3F), the effect of g-IFN was predominantly seen
between 3 h and 1 day. It is notable (and will become
more evident in Fig. 7) that the main effect of g-IFN in
enhancing killing coincides with an innate early phase of
bacterial killing. In another series of experiments, we
found the same pattern with M. tuberculosis in response
to g-IFN (Fig. S1). We presume that the main effect of
g-IFN in the killing process operates via the RNI system.
Because the mouse macrophages made NO in
response to the mycobacteria, we next correlated the
expression of iNOS, the enzyme that makes it after infec-
tion of J774 cells with BCG and M. bovis. Using immun-
ofluorescence microscopy, we could not detect any signal
for iNOS in uninfected cells (Fig. 4A) whereas detected a
significant increase in cytoplasmic labelling for iNOS
already after 1 h infection with M. bovis (Fig. 4C) or BCG
(Fig. 4B). No specific association of iNOS with phago-
somes of either BCG or M. bovis was seen, in agreement
with the data of Anes et al. (2006) and other studies
(Miller et al., 2004). After treatment of uninfected (Fig. 4D)
or infected macrophages (Fig. 4E) with g-IFN, a general
increase in iNOS labelling was clearly observed. Immun-
ofluorescence microscopy was a more sensitive estimator
of iNOS than Western blotting. Although by Western blot,
iNOS could be detected after treatment with g-IFN, no
band was detectable in untreated infected cells (Fig. 4F).
Thus, conditions where NO levels are high correlate
with an increase in iNOS protein levels, as expected.
Collectively, these data lead us to conclude that increased
iNOS activity early, but not late in infection plays a role
in killing mycobacteria in mouse cells. g-IFN treatment
enhances the early killing phase, predominantly by stimu-
lating iNOS activity. However, the fact that human mac-
rophages have a similar capacity to kill non-pathogenic
and pathogenic mycobacteria but have no iNOS activity,
shows clearly that RNI is not only or the main killing
mechanism in macrophages.
Phagosome–lysosome fusion and pH
We next addressed the role of phagosome maturation
in mycobacteria killing, focusing on phagosome-late-
endosome/lysosome acidification and fusion. This is often
assumed to be the major factor in the ability of the bac-
teria to survive (no fusion) and for the macrophage to kill
them (fusion). If this is indeed the key factor, we would
predict that, by following phagosome maturation using a
range of markers in different cell types infected with BCG
and M. bovis, we would see significant correlations
between the extent of fusion and the degree of killing.
Late endocytic organelles as well as late phagosomes
are predominantly acidic, and the acquisition of a low pH
is an accepted marker for mature phagosomes (Malik
et al., 2000; Kusner and Barton, 2001; Vieira et al., 2002;
Kusner, 2005; Russell, 2005; Deretic et al., 2006). Using
the fluorescent dye lysotracker DND99, which accumu-
lates in acidic compartments (pH < 6), the acidification of
BCG and M. bovis was monitored by confocal micro-
scopy, focusing on J774 and HMDM cells (Via et al., 1998;
Anes et al., 2006). In J774 cells, only around 10% of both
types of mycobacterial phagosomes were acidic 3 h after
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Fig. 3. Role of NO in M. bovis spp. survival. In vitro susceptibility of M. bovis BCG (GFP) (A) and M. bovis (B) to different concentrations of
the NO donor NOC-18. Effects of L-NAME, NOC-18 and g-IFN on intracellular survival of BCG (GFP) (C) or M. bovis (D) evaluated after 1 day
infection.
E and F. Colony-forming unit (cfu) estimates after 7 days of M. bovis BCG (GFP) (E) or M. bovis (F) in J774 macrophages treated with or
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day 3 these values decreased again to around 10%
(Fig. 5A). In contrast, in HMDM more BCG-containing
phagosomes acidified at 3 h, but thereafter, the fraction
of acidified phagosomes remained below 10%. The frac-
tion of acidic M. bovis-containing phagosomes never
exceeded 10% and, after 3 days, only 5% were acidic
enough to accumulate lysotracker (Fig. 5B).
We next followed phago-‘lysosome’ (late endosome
and lysosome) fusion using an assay we recently
introduced, in which nanogold particles labelled with
rhodamine are internalized by late endocytic organelles
(Fig. 5C and D; Anes et al., 2006). Under all conditions, in
J774 and HMDM cells less than 10% of the phagosomes
containing BCG or M. bovis fused with rhodamine-
labelled ‘lysosomes’. In HMDM cells, at later time points
less than 3% M. bovis phagosomes had fused with this
marker.
When J774 were fed with heat-killed BCG, the fraction
of acidified phagosomes increased from 25% at 3 h to
around 80% after 1 day (Fig. 5E). These argue that pha-
gosome containing dead bacteria matured efficiently, as
expected (Clemens and Horwitz, 1995; Clemens, 1996;
Vergne et al., 2005). The fraction of phagosomes that
fused with lysosomes also increased between 3 h and
1 day; however, whereas only 40% of the heat-killed BCG
phagosomes had fused with lysosomes, the fraction that
acidified was 80%. This difference in the levels of acidifi-
cation and fusion can be rationalized by our recent obser-
vation (Anes et al., 2006) showing that, in J774 cells, the
bulk of V-ATPase is delivered to phagosomes from a late
endocytic vesicle that is distinct from the ‘classical’ late
endosomes that label with LAMP-1 (Griffiths et al., 1988;
Xu et al., 1994; Clemens and Horwitz, 1995).
Using a different late endosome marker lysobisphos-
phatidic acid (LBPA) (Schmid and Cullis, 1998) with live
BCG-infected J774 and HMDM cells, a similar low fraction
of phagosomes was found to colocalize with this marker
(Fig. 5F). These data collectively show that overall, less
than 10% of BCG or M. bovis fused with late endosomes
and lysosomes, or acidified in J774 or HMDM cells. When
one compares the overall pattern of phagosome matura-
tion over the infection period with the growth of BCG or




Control g-IFN Control g-IFN
Average SD Average SD Average SD Average SD
3 h < 1.0a 0.40 < 1.0a 0.40 < 1.0a 0.40 < 1.0a 0.40
1 day 1.0 0.5 18.7 0.12 1.0 0.05 25.4 1.23
2 days 2.8 0.40 20.5 0.09 1.3 0.08 25.3 0.91
3 days 3.2 0.20 4.4 0.03 1.8 0.05 5.6 0.06
NO estimated by the Griess reagent at different times after infection of J774 cells with BCG or M. bovis with and without g-IFN. At values below
1 mM the results are less precise.
a. Extrapolated from the reference standard curve.
Fig. 4. Localization of inducible NO synthase
(iNOS) in J774 macrophages.
Immunofluorescence labelling for iNOS in
untreated and uninfected J774 cells (A), in
macrophages infected with BCG (GFP) (B) or
with M. bovis (C) for 3 h.
D and E. The effects of g-IFN treatment on
uninfected cells (D) or cells infected with BCG
(GFP) (E). In all images, iNOS was labelled
with Cy3 (red channel) and Mycobacterium
spp. were labelled with GFP (BCG) or Oregon
green (M. bovis) (green channel). Western
blots for iNOS during J774 macrophages
infection with BCG (GFP) during 3 h and
1 day. Macrophages treated with g-IFN were
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Fig. 5. Phagosome acidification and fusion with late endosomes and lysosomes. Acquisition of lysotracker and rhodamine gold by live BCG
or M. bovis phagosomes in J774 (A and C) or HMDM (B and D) and heat-killed BCG phagosomes in J774 (E). Shown in panel F is the
acquisition of LBPA and gold by live BCG phagosomes either in J774 or in HMDM. The effects of bafilomycin A1 in macrophages infected with
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M. bovis (Fig. 2G and H), it is difficult to observe any clear
correlations.
In our earlier study on M. smegmatis in J774 cells, we
showed that a low pH in the phagosome contributes to the
killing of these bacteria because the V-ATPase inhibitor
bafilomycin A1 reduced the extent of killing (Anes et al.,
2006). Given that even the early phagosome stage has a
pH around 6.2 (Russell, 2001; Yates et al., 2005) that will
not be detected by lysotracker, we asked whether lower-
ing the pH had any effect on the survival of BCG or
M. bovis in vitro. A prior study (Chapman and Bernard,
1962) had shown that M. tuberculosis has an optimal pH
for growth in vitro at pH 6.2 but there was significant less
growth as the pH was reduced. In contrast, M. smegmatis
is highly robust and can grow well in a wide pH range
(from 4.5 to above 8), as might be expected for an organ-
ism found naturally in soil. As observed in Table 2, while
M. bovis was not affected in our experiments by pH down
to 5.5, BCG was more susceptible, with 20% even being
killed at pH 6.5. At pH 4.5, however, 40% of M. bovis and
over 80% of BCG were killed.
If we extrapolate these pH values to those found in the
different phagosomes in macrophages – early phago-
somes around pH 6.2 and late phagosomes down to
pH 4.5 (Yates et al., 2005), these data predict that, in
‘non-matured’ early phagosomes, BCG could be exposed
to a partial bactericidal effect of pH whereas M. bovis
would not be affected by the mild acidity. In contrast,
should either bacteria find themselves in fully matured
phagosomes (pH 4.5–5), both would be susceptible to low
pH killing. In order to test this hypothesis, we used the
V-ATPase inhibitor bafilomycin A1 to neutralize the pH of
all endocytic compartments. We showed earlier that this
treatment significantly reduced the killing of M. smegmatis
in J774 cells (Anes et al., 2006).
J774 cells infected with BCG or M. bovis were treated
with bafilomycin A1 at the different time windows indicated
in Fig. 5G and H. The treatment with 25 or 50 nM of the
drug led to a significant increase in growth of BCG between
the 3 and 24 h time points and at the 1–3 day period, but it
had no effect at subsequent times up to day 7 (Fig. 5G). For
M. bovis, a similar result was seen with bafilomycin (at 50
but not 25 nM) between 3 and 24 h, whereas no effect was
seen at later times (Fig. 5H). These data show that: (i) a low
pH does contribute significantly to killing of both BCG and
M. bovis, but this effect is restricted to the early phases of
the infections; and (ii) the period (up to day 1) in which BCG
is resistant to pH is significantly longer (up to 3 days) than
for M. bovis (up to 1 day). As shown below, these periods
coincide precisely with initial strong bacteriocidal stages in
macrophages that are different for the two mycobacteria.
All mycobacteria are exclusively in phagosomes
Although it is generally accepted that intracellular myco-
bacteria in macrophages are always enclosed by mem-
branes of phagosomes or phagolysosomes, two earlier EM
studies suggested that M. tuberculosis could under some
conditions escape out of the phagosome ( Myrvik et al.,
1984; McDonough et al., 1993). This idea, received with
scepticism in the field, was recently re-awakened by a
more convincing EM study by Peters and collaborators
(van der Wel et al., 2007). Using the Tokuyasu cryo section
EM method following chemical fixation, these authors pro-
vided a striking scenario in which M. tuberculosis H37
Rv-enclosing phagosomes in human blood macrophages
and dendritic cells fused significantly with lysosomes after
2 day infection (as monitored via acquisition of LAMP-1,
CD63 and cathepsin D). After this period, the phagosomes
were found to lyse and M. tuberculosis escaped into the
cytoplasm, where bacterial growth was observed. In con-
trast, BCG remained within phagosomes at all times after
infection. This result fits well with the behaviour of the
closely related pathogen M. marinum (Stamm et al., 2003;
2005), which was even able to move actively through the
cytoplasm by actin comets, similar to Listeria and other
pathogens (Cossart and Sansonetti, 2004).
The possibility that M. bovis in particular could escape
into the cytoplasm in our experiments offered an attractive
alternative hypothesis to explain the lack of obvious
correlation between its intracellular growth/killing and the
fraction of fully matured phagosomes. We found no
conditions in this study (even after treatment with g-
IFN; results not shown) in which BCG-, M. bovis- or
M. tuberculosis-containing phagosomes showed an index
of phagolysosome fusion much above the 10% value, at
least up to 7 days. Similar conclusions were drawn by
Armstrong and Hart (1971) after monitoring the infec-
tion with M. tuberculosis up to 15 days in primary
macrophages. Nevertheless, perhaps this abrupt matura-
tion of pathogen-containing phagosomes seen by Van der
Wel et al. (2007) might have occurred too rapidly in our
cell systems. If the bacteria were in the cytoplasm, they
Table 2. Effects of pH on BCG and M. bovis in vitro.
pH
Mycobacteria killed
compared with the control (%)
M. bovis BCG
1 day 7 days 1 day 7 days
6.5 – – 20 10
5.5 – – 20 10
4.5 40 40 84 84
Colony-forming unit (cfu) estimate of BCG and M. bovis incubated at
different pH values. The data are presented as the percentage of
bacteria killed relative to the control (bacteria grown in standard
medium) after 1 and 7 days.
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could not be expected to contain any lysosomal marker.
Clearly, this question could only be addressed using
electron microscopy. An obvious worry for any electron
microscopic (EM) study using conventional fixation is
the question of fixation artefacts, a problem that can be
particularly difficult in preserving membranes (Griffiths,
1993). Only by use of cryo-immobilization methods such
as freeze substitution or cryo-electron microscopy of vit-
rified sections (CEMOVIS) (Al Amoudi et al., 2004) can
one be sure to avoid all chemically induced artefacts.
However, if pathogens are to be investigated by these
more modern technologies, it requires the combination of
a high-pressure freezer machine in a biosafety level 3
facility, a combination that we currently do not have.
There is, however, one proviso for using conventional
chemical embedding that makes this approach suitable
for analysing pathogen phagosomes. While there is
always the possibility that phagosomal membranes can
lyse, or even perhaps disappear in response to fixation,
we consider it highly unlikely that a bacterium free in the
cytoplasm can acquire a membrane artifactually as a
result of this procedure. This discussion is highly relevant
to interpretation of EM images of chemically fixed speci-
mens, and to the data we now present.
We chemically fixed J774 or HMDM infected with
BCG, M. bovis or M. tuberculosis with glutaraldehyde,
post-fixed in osmium and uranyl acetate, and embedded
the samples in epoxy resin. Alternatively, after only glu-
taraldehyde fixation the cells were infused with sucrose
and prepared for cryo-sectioning (Tokuyasu, 1973);
these were contrasted with either uranyl acetate or
ammonium molybdate in combination with methyl cellu-
lose (Griffiths, 1993). Using both approaches, thin-
section EM analysis showed unequivocally that all of the
bacteria we observed within the macrophages were
invariably surrounded by a phagosome membrane at all
times up to 6 day infection. Examples of these images
are shown in Fig. 6. This rules out the possibility that
any cytoplasmic mycobacteria exist under our conditions
and supports the observations of Armstrong and D’Arcy
Hart (1971), who found M. tuberculosis to be enclosed
by a phagosomal membrane at all times over 2 weeks of
infection.
Killing of mycobacteria occurs in mature and
non-mature phagosomes
From the above results, both BCG and M. bovis reside in
macrophages in phagosomes that we can operationally
separate into ‘early’ or non-matured phagosomes (not
fused with ‘lysosomes’ and lysotracker negative) and ‘late’
or mature phagosomes (fused with lysosomes and
lysotracker positive). The vast majority (90%) of both BCG
and M. bovis phagosomes were in early (non-mature)
phagosomes. We wanted to distinguish between the two
extreme models presented in Introduction: first, killing
occurs only after a live bacterium finds itself in a matured
phagosome; and second, killing occurs in early phago-
somes and is perhaps a prerequisite for some of these
phagosomes to mature into a hydrolytic compartment that
degrades the pathogens.
To address this issue, we set up an experiment in which
we could distinguish between live and dead bacteria per
cell, using an approach similar to that described by Anes
et al. (2006) and Barker et al. (1997). For this, we infected
J774 cells with M. bovis that had been surface-stained
with Oregon green or with GFP-BCG. Subsequently, the
cells were lysed and the recovered bacteria were stained
with propidium iodide, a red dye that is unable to cross
intact bacterial membranes but stains nucleic acid in dead
bacteria. This allowed us to distinguish between dead (red
or yellow) and live bacteria (green) and, by separately
counting the number of macrophages, we could relate the
numbers of bacteria to the numbers of cells. Importantly,
the viability and the total number of macrophages during
the time of the experiment remained constant. Less than
1% of macrophages could be stained with trypan blue in
infected cultures for 7 days.
The quantitative analysis of this experiment was quite
revealing (Fig. 7A). With both BCG and M. bovis, the
number of green (live) bacteria dropped at a similar initial
rate, giving a total killing of around 40% during the first
day of infection (Table 3). From the data in Figs 3C and D
and 5G, it seems likely that RNI and a low pH are the
major factors responsible for this early killing of both
bacteria. In the case of M. bovis, day 1 was the start of a
continuous growth period, whereas for BCG, killing pro-
ceeded until day 3, when a static condition was reached.
The initial decrease in the number of green bacteria, up to
day 3, was, however, not correlated with an increase in
the number of red/yellow bacteria, as we expected.
Rather, this number was kept at a consistently low value
of around 0.5–1 bacteria per cell, for both M. bovis and
BCG. Our interpretation at this point is that we have dead
bacteria in different stages of digestion and only the best-
preserved ones would be recovered after macrophages
lysis and propidium iodide staining. Clearly, these killed
bacteria must be cleared relatively fast, and at a similar
rate for both bacteria. Taking this into account, we con-
sider that the rate of disappearance of the green bacteria
provides the best independent estimate of the killing rate.
This assumption was supported by the excellent correla-
tion between cfu (Fig. 7B) and the different kinetics of
disappearance of BCG and M. bovis green bacteria
(Fig. 7A).
During the first 24 h, the rate of killing for BCG and
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the pathogenic M. bovis are subjected to a similar
macrophage-killing potential early in infection. After 1 day,
M. bovis strikingly switched to a state of growth, with the
number of green (live) bacteria increasing to give an
average of 8 bacteria per cell after 7 days, as seen by direct
microscopy counts and by cfu estimations (Fig. 7A and B).
So the major difference between BCG and M. bovis is that
BCG continuously suffers a net loss until a steady state is
reached after 3 days, whereas M. bovis is able to switch to
a growth phase after 1 day – we presume that this involves
a signalling switch from a pro-inflammatory signalling state
of macrophages to an anti-inflammatory one (L. Jordao
et al., submitted). Nevertheless, because a constant
number of dead bacteria are seen at all times for M. bovis
(Fig. 7A and B), it argues that the net growth seen for
M. bovis reflects a balance between growth and a constant
rate of killing; a similar conclusion was made for M. mari-
num in phagosomes (Barker et al., 1997). Although no net
growth is seen for BCG at any time, the constant ratio of live
to dead bacteria argues that this bacterium is also at a
steady state with continuous growth and killing. Because
roughly half of the BCG population in these late infection
period is dead, and only 5–10% are in phagosomes that
have fused with lysosomes, we interpreted these data to
mean that some bacteria must be killed in non-matured
phagosome.
Fig. 6. Mycobacterium spp. reside in a
phagosome compartment at all infection
times.
A–D. Epoxy resin plastic section of J774
macrophages infected after 3 day infection
with M. bovis (A and B) or M. tuberculosis
H37Rv (C and D).
E and F. Thawed cryo-sections of HMDM
infected for 3 days (E) and 5 days (F) with
M. bovis; sections stained with ammonium
molybdate and methyl cellulose. In all panels,
mycobacteria are marked with an asterisk (*),
and arrowheads indicate the membrane of
phagosomes that enclose the mycobacteria.
Plasma membrane (PM), nucleus (Nu) and
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We also analysed the rate of disappearance of heat-
killed GFP-BCG and M. bovis taken up by phagocytosis
by J774 cells. The rate of clearance was identical for both
bacteria (Table 3), with 67% of these killed bacteria
having disappeared from cells between 3 h and 1 day.
Between 1 and 3 days, almost all remaining bacteria were
eliminated (n.b. for this experiment, we used a low
number of bacteria for infection in order to more clearly
visualize the bacteria; see below).
A comparison of Fig. 7A and B with Fig. 5G and H
reveals an interesting correlation. For both BCG (with net
killing until day 3) and M. bovis (killed until day 1), these
periods of killing coincided precisely with the times that
blocking phagosomal acidification prevents killing. This
provides more compelling evidence that low pH is directly
involved in the initial net killing period, but not thereafter.
Under some conditions, particles within phagosomes
can exit cells by exocytosis of the phagosomes (Di et al.,
2002). We therefore hypothesized that the potential live
(green) bacteria that were ‘lost’ from cells might be exo-
cytosed after (or even before) killing. However, extensive
microscopy and cfu counts of live and killed bacteria on
the surface of cells or released into medium showed no
significant release of bacteria to the extracellular space
(results not shown). This indicates that the digestion and
clearance of bacteria must occur in the lumen of the early
or late phagosomes.
Modelling intracellular transport and killing of BCG
We then assessed whether the data in Fig. 7A and B
for BCG could be fitted to a simple model considering
two compartments (early and late) and the rates of bac-
terial growth, killing, disappearance and transport be-
tween compartments (i.e. phagosome maturation). We
described the system by defining the seven different
reactions shown in Fig. 7D, each having a rate constant,
k1–7. A set of differential equations were generated in
the COPASI modelling program (see Experimental proce-
dures and Fig. 7C). This elegant program allows one to
change each constant independently, and then the
program is run to see what pattern of curves emerge
for the number of bacteria over time. COPASI can be
instructed to find the set of constants that best repro-
duce the observed values. For this exercise, we used all
available experimental evidence we had. The data for
dead and live bacteria at different times after internal-
ization were taken from Fig. 7A (BCG). The values for
the fraction of bacteria in early compartments were
taken from Fig. 5C (BCG). The dynamics of transport to
late compartments (along with phagosome maturation)
and the disappearance from macrophages of dead BCG
were those shown in Fig. 5E and Table 3.
The general features for BCG intracellular transport
and survival in J774 macrophages i.e. most bacteria
present in early compartments at all times after infection,
a stable amount of dead microorganisms, and an expo-
nential decrease of live bacteria could be reproduced
quite well by two totally different scenarios (Fig. 7C and
D). In the first (model A), the majority of the bacteria is
killed in, and disappears from, early compartments,
whereas in the second (model B), the majority of the
bacteria are first transported to late compartments,
where they are quickly killed and degraded (Fig. 7D). It
is interesting to notice that both models require killing in
the early compartments, as postulated by Armstrong and
D’Arcy Hart (1971), in order to fit the experimental data.
However, whereas this process is the main player in
model A, it plays a quantitatively less important role in
model B. The time-limiting step for BCG disappearance
in the first model is the killing and degradation in the
early compartments, whereas for the second, it is the
transport to late compartments. It is worth mentioning
that we could not find any other set of parameters that
fit the experimental data, although calculations were
started from eight different initial conditions.
At first glance, model A was attractive because it seems
to be consistent with the low fraction of bacteria in phago-
lysosomes and the low rate of killed bacteria. If the majority
of the bacteria are cleared from an early compartment (a
phenomenon that has never been observed), it might
explain why we detected such apparent low values for
Fig. 7. Evaluation of mycobacteria growth/survival by different methods and the COPASI models for BCG transport and killing in J774
macrophages. Evaluation of live and dead M. bovis spp. in J774 macrophages over 7 days by microscopy (A) or by cfu (B). Table 3 shows a
numerical summary of parameters calculated from panels A and B.
C. The results of two modelling scenarios (model A and model B). Filled symbols represent the experimental data from panel A, whereas open
symbols indicate the values obtained from the models.
D. The seven reactions modelled – for more details see Supplementary material (COPASI file). In the models, two phagosomal compartments
are considered (early or non-matured, and late or matured). The bacteria can divide, and be killed, digested or transported from early to
late compartments. Kinetics constants are: k1, rate of transport (by maturation) from early to late compartments for live BCG; k2, rate of
transport from early to late compartments for killed BCG; k3, rate of killing of BCG in early compartments; k4, rate of killing of BCG in late
compartments; k5, rate of disappearance of BCG from early compartments; k6, rate of disappearance of BCG from late compartments; k7,
rate of duplication of BCG in early compartments. The first numerical value for each arrow is the kinetic constant k expressed as 1 h-1 *102.
The numbers in parentheses give the half-life for reaction 1–6 (time in hours to transport, kill or digest 50% of the bacteria) or the doubling
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phagolysosome fusion as well as the relatively low
numbers of dead bacteria. However, a deeper analysis
makes us favour much more the second model B, in which
an important small fraction of bacteria are killed in early
phagosomes. Both live and killed bacteria phagosomes
have a relatively low chance of undergoing full maturation,
but when they do, they face a compartment where the live
bacteria are rapidly killed (30 min), and both this pool, and
the bacteria already killed in early phagosomes, are rapidly
digested and disappear (60 min). In model B the almost
perfect fitting of theoretical values to our experimental data
is observed with a duplication time for BCG (k7 in Fig. 7D)
of 17 h. This value, which was important for the curve
fitting, is within the range estimated for the cell division time
of 23 h for BCG growing in vitro (Beste et al., 2005). In
contrast, in model A the fitting of theory to experimental
data necessitated a k7 value of over 500 h, a value that is
totally unrealistic.
Discussion
Here, we addressed those factors that were believed to
contribute to killing mycobacteria in macrophages and
investigated the interactions between three mycobacte-
ria, M. smegmatis, BCG and M. bovis, in up to six dif-
ferent cell types. We started our analysis by further
investigating M. smegmatis, which we have recently
characterized in great detail in J774 cells (Anes et al.,
2006). In these cells, M. smegmatis is exposed to a first
killing phase (1–4 h), a subsequent growth phage (4–8/
9 h) and two further killing stages with different kinetics
(9–24 h). It was striking that the other three cell types
we tested (Raw, mouse BMM and human HMDM) all
showed the same kinetics of efficient killing between 1
and 4 h; this argues that the bacteria bind receptors
which induce the same dynamics of early signalling in all
the cells. At subsequent times, the pattern of M. smeg-
matis growth in BMM cells was almost identical to J774
cells, whereas different patterns were seen with Raw
and HMDM, although all the cells effectively cleared
M. smegmatis by 48 h.
Differences between cells became much more appar-
ent when we compared six different macrophage types
following infection with M. bovis BCG (GFP). No easily
discernable pattern emerges from this analysis, arguing
that each combination of cell–mycobacterium tends to
behave differently. Further, the ability of a cell type to kill
BCG or M. bovis could not be easily correlated with their
ability to kill M. smegmatis.
Extensive literature argues that NO produced by iNOS
in macrophages is a crucial killing factor for mycobacteria
in macrophages (Macmicking et al., 1997; Rich et al.,
1997; Jagannath et al., 1998; Long et al., 1999). Our data
lend support to this hypothesis, and to the notion that the
pathogenic M. bovis is more resistant to the killing effects
of NO in vitro compared with BCG. There is also signifi-
cantly less NO produced from M. bovis- relative to BCG-
infected mouse macrophages, although these levels
could be increased dramatically in both infections with
g-IFN treatment; this resulted in a slight increase in killing
of BCG and a significant increase in killing M. bovis after
1 day, but not at later days of infection. Effects of g-IFN
in killing mycobacteria in macrophages have been
described earlier (Denis, 1991; Via et al., 1998; Schaible
et al., 1999). In mouse cells, there was a good correlation
between the levels of NO and the killing of mycobacteria,
with both higher levels of NO and iNOS-dependent killing
being restricted to the first 1–2 day infection. A similar
pattern was seen earlier with M. smegmatis in J774 cells,
in which the NO production and iNOS-dependent killing
was restricted to the first 2 h of infection. That RNI is not
the only killing mechanism is also seen by the fact that
human macrophages are unable to show iNOS activity
but are still capable of killing mycobacteria. Here, HMDM
produced undetectable levels of NO but were neverthe-
less capable of killing M. smegmatis in the first 4 h infec-
tion at the same rate as the three types of mouse cells
(Fig. 1A–D).
An additional factor that was important for the early
killing potential of macrophages was a low pH. When
BCG- or M. bovis-infected J774 macrophages were
treated with the V-ATPase inhibitor bafilomycin A1, there
was a significant increase in bacterial growth at the
3–24 h period for M. bovis, and between 3–24 h and
1–3 days for BCG. However, this drug had no effect at
later times of infection for either bacteria up to 7 days
(Fig. 5G). The early infection period where a low pH facili-
tates killing coincides with the period of iNOS activity, and
it is known that a low pH synergizes with the RNI system
to induce more potent killing activity (Rhoades and Orme,
1997). It is striking that the period where a low pH is
needed for net killing of both bacteria coincides precisely
with the early infection period in which the bacterial counts
were decreasing strongly (the pro-inflammatory phase),
as assessed by both direct microscopy estimates and cfu
(Fig. 7A and B). We propose that the combination of RNI
and a lowered compartment pH synergize to provide the
first killing process. The early mycobacterial phagosomes
have a pH of around 6.2, while the late ones are at 5 or
slightly below (Sturgill-Koszycki et al., 1994; Clemens and
Horwitz, 1995; Yates et al., 2005). Because NO and its
relatives are freely diffusible, it is conceivable that its
combination with a lowered pH in early or late endocytic
organelles could induce killing in either compartment; our
data do not allow us to distinguish between these options.
The observation that blocking phagosome acidification at
days 3–7 had no effect on the survival of BCG or M. bovis
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must be continually killed, even after the RNI wave, it
argues that whatever mechanism that kills them is not
dependent on a low pH.
The interpretation of our data was not straightforward,
given the many different potential reactions that operate in
the highly dynamic system – in which a variable fraction of
the pathogens can divide and a different, variable fraction
can be killed at any time by the macrophage. We therefore
carried out a more detailed analysis of the BCG and
M. bovis infections by estimating the total numbers of live
and killed bacteria in the cells at different times of
infection. Both bacteria were initially killed rapidly until day
1 (M. bovis) or day 3 (BCG). Thereafter, M. bovis switched
to a robust net growth phase while BCG retained a con-
stant low level of live bacteria per cell until day 7. Surpris-
ingly, the fraction of bacteria that were rod-shaped but
accessible to propidium iodide, and therefore presumed
to be dead, remained at a constant value of around one
dead bacterium per cell at all infection times for both BCG
and M. bovis. Clearly, the killed bacteria must be digested,
and the number of dead ones identified at any stage
represents the balance between the rate of killing and the
rate of digestion.
The use of the COPASI program to model our data
turned out to be a very powerful tool. When one deals
with complex multistep processes such as phagosome
maturation, pathogen growth and killing processes, it is
difficult to make an intuitive interpretation of the data. In
fact, without such modelling we would have concluded
that the quantitatively most significant killing of the bac-
teria occurs in an early compartment, in agreement with
the classical study by Armstrong and D’Arcy (1971).
However, the theoretical modelling led us to a different
conclusion. In this exercise the overall process of infec-
tion is separated into seven distinct reactions with their
own rate or activity constants. The COPASI program then
allows one to find estimates for these seven parameters
that gives the best fit of the dynamics of the bacterial
growth/killing with the observed experimental data
(Fig. 7A and B). We found two quite different potential
‘solutions’ that accurately mimicked the experimental
data (Fig. 7D). The main difference between the two
models is that in model A, the majority of bacteria are
killed and cleared from early phagosomes whereas in
model B, these processes predominantly occur in late
compartments. As already pointed out, the latter model
makes more sense, for example because it assumes a
reasonable doubling time for BCG in the macrophage of
17 h whereas model A predicts a totally unrealistic value
for this parameter of over 500 h. Moreover, the input
value of 17 h in model A was essential for the good fit
between theory and experiment; with slightly higher or
lower values, there was poor agreement between theory
and experimental data.
Of course, a model that accurately fits the data is far
from guaranteeing that its assumptions are correct; after
all, model A, which we believe is unrealistic, also gives an
excellent concordance between theory and experiment.
Nevertheless, a model can lead to predictions that can be
tested in further experiments. The preferred model B pre-
dicts that: (i) a small but significant degree of BCG killing
(and presumably M. bovis) must occur in early phago-
somes; (ii) a rate-limiting step occurs for the maturation of
phagosomes containing both live and killed bacteria; (ii)
once phagosomes have matured, the live bacteria are
killed very rapidly, on average in 30 min; and (iv) bacteria
that were killed in early phagosomes and those that are
killed in late phagosomes are rapidly digested, and dis-
appear from the system within 1 h. A recent study by
Majlessi et al. (2007) provides support for the hypothesis
that both the early and late mycobacterial phagosome can
show hydrolytic activity because the same level of myco-
bacterial antigen presentation was seen, irrespective of
whether the bacteria resided in early or late phagosomes.
We are currently setting up experiments to test some of
these predictions, most notably the idea that the bacteria
are killed and removed from the late compartments in a
relatively short period, using live cell-imaging methods.
Our data collectively argue that, for BCG and
M. bovis, the killing by macrophages occurs in two
distinct phases: the first, an early low pH- and RNI-
dependent process, and the second, independent of
both. The hypothesis emerges that multiple bacteriocidal
factors must be delivered into the pathogenic myco-
bacterial phagosome. The first, early phase may be
explained by the combination of a pH below neutrality
and RNI. The second, later phase that occurs for sure
after (and perhaps also before) the RNI wave evidently
occurs independently of a low pH. We presume that two
sets of hydrolytic enzymes or factors must contribute to
the small degree of killing postulated to occur in early
phagosomes, and to the more extensive killing that likely
occurs in late phagosomes. Factors such as cathelicidin,
which has recently been implicated in killing M. tubercu-
losis (Liu et al., 2006), can be expected to contribute to
the overall killing process. Although hydrolases are gen-
erally more active at a lowered pH, the late killing factors
that we observed in this study were not affected by
blocking the proton pump with bafilomycin. However,
some lysosomal enzymes have an optimal activity at a
neutral pH (Butor et al., 1995), and even some enzymes
with a low pH optimum may still retail significant activity
at neutral pH values. The identification of all the factors
within both early and late phagosomes that have the
potential to kill pathogenic mycobacteria, especially
M. tuberculosis, is now crucial to our understanding of
the macrophage-killing potential, and to evolve therapies
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Experimental procedures
Bacterial culture conditions
Mycobacterium tuberculosis H37 Rv, M. bovis BCG Pasteur
(ATCC35734), M. bovis BCG harbouring a pMN437 plasmid, and
a strain of M. bovis genetically characterized isolated from a
bovine were grown on Middlebrook’s 7H9 broth medium (Difco)
supplemented with 10% OADC (v/v) and 0.05% Tween 80 (v/v)
until exponential phase at 37°C/5% CO2. Media were supple-
mented with 50 mg ml-1 hygromycin (Roche) for selection of
recombinant mycobacteria.
Cell line culture conditions
The mouse macrophage cell lines J774.A1 and Raw 264.7
were cultured as described previously. Two days before infec-
tion, macrophages were seeded onto 24-well culture dishes and
left for 2 days in a 5% CO2 incubator at 37°C (105 macro-
phages ml-1).
THP1 cells were grown in RPMI 1640 (Gibco) supplemented
with 10% fetal bovine serum (FBS; Gibco), 1% Hepes (Gibco),
penicillin and streptomycin (Gibco). The cells were seeded onto
24-well culture dishes at a density of 5 ¥ 105 cells ml-1 and
treated overnight with 5 nM phorbol myristate acetate (Sigma).
Then cells were washed three times with PBS and incubated for
one more day.
Human monocyte-derived macrophage (HMDM)
isolation and culture
Human monocyte-derived macrophages were prepared from
venous blood from healthy volunteer donors using density gradi-
ent centrifugation as described before (Mendez-Samperio et al.,
2004). Cells were plated at a density of 2 ¥ 106 cells ml-1 and
incubated for 3 days with RPMI 1640 supplemented with 30%
FCS and 10% human-type AB serum (Sigma). Then cells were
washed three times with warm 1% FCS in PBS and cultured for
7 days before infection.
Bovine monocyte-derived macrophage (BMDM)
isolation and culture
Bovine monocyte-derived macrophages were prepared from
venous blood from healthy, 8- to 9-month-old male Holstein Frie-
sian, bovines using density gradient centrifugation. The protocol
used was similar to that described above for HMDM with the
following differences: density gradient (NycoPrep 1.077A from
AXIS-SHIELD) and the supplementation of the RPMI 1640
medium. Instead of 10% human-type AB serum, 10% homolo-
gous bovine serum was used.
Bone marrow-derived macrophage (BMM) isolation
and culture
Experiments were performed with 3-week-old C57BL/6 male mice
from Jackson Laboratory. Mice were killed by cervical dislocation,
and the femur and tibia bones were removed. The bones were
trimmed at both ends, and the marrow was flushed out with
5–10 ml of RPMI containing 10% FCS using a 23-gauge needle.
The cell suspension was centrifuge for 4 min at 900 g, and the
pellet was gently ressuspended in RPMI supplemented with 10%
FCS, 1% penicillin/streptomycin, 1% nonessencial amino acids
(Gibco) and 15% L929 supernatant, and plated into bacterial Petri
dishes.After 3 days, monolayers were washed with warm 1% FCS
in PBS and incubated for another 3 days. At this point, more than
95% of the cells were CD14 (BD Pharmigen) positive by flow
citometry. Cells were scraped and plated at a density of 2.5 ¥ 105
cells ml-1 and incubated overnight before infection.
Macrophage infection
Bacterial cultures on exponential grown phase were pelleted,
washed twice in PBS pH 7.4, and resuspended in PBS to a final
concentration of 5–10 ¥ 109 cells ml-1. Single-cell suspensions
were generated by 2 min pulse in a water-bath sonicator (room
temperature), followed by passage through a 23-gauge needle to
disrupt remaining bacterial clumps. Before infection, residual
bacterial aggregates were removed by low-speed centrifugation
(120 g) for 2 min. Single-cell suspension was verified by light
microscopy.
Before infection, non-adherent cells were removed by wash
with PBS, and the medium was replaced by antibiotic-free medium
supplemented with 10% FBS. To achieve 2–8 bacilli per macro-
phage after 3 h uptake, an OD600 ~0.1 was used for all the
macrophages used except HMDM. For these macrophages, an
OD600 ~0.01 was used instead. The cells were washed twice with
PBS to remove free mycobacteria. At infection time (3 h) and after
several days (3, 5 and 7 days), infected macrophages were
washed with PBS and lysed with 1% Igepal (Sigma) solution in
water. Serial dilutions of the lysate were prepared in water and
plated at Middlebrook 7H10 medium supplemented with OADC.
After about 3 weeks of incubation at 37°C, colonies were counted.
For M. smegmatis, a similar protocol was used with the follow-
ing differences: (i) an OD600 ~0.1 was used for all the macro-
phages; and (ii) cells were allowed to uptake bacteria only for 1 h.
Treatment with g-IFN, inhibitors and NOC-18
When required, cells were treated with murine g-IFN (50 IU)
overnight before infection. g-IFN was a kind gift from the Centra-
lised Facility for AIDS Reagents.
When treated with iNOS inhibitor N-(G)-nitro-L-arginine methyl
ester hydrochloride (500 mg ml-1 L-NAME; Sigma), this com-
pounds was added to the medium 1 h before infection and left
until the end of the experience. When treated with NOC-18 (0.1
or 1 mM; Calbiochem), this compound was added to the medium
at time zero and left until the end of the experience. Chemicals
were renewed during the course of the experiments according to
their half-lives. The V-ATPase inhibitor, bafilomycin A1, 25 or
50 nM (Sigma), was added to the medium in the following time
windows: 3 h-1 day, 1–3 days, 3–5 days and 5–7 days.
Nitric oxide
Culture supernatants were collect at several time points for deter-
mination of nitrite contents. Nitrite concentration indicating the
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Mycobacterium bovis spp. in vitro sensitivity to NO was deter-
mined using serial dilutions of an 1000 mM NOC-18 solution in
DMEM supplemented with 10% FCS. After 1, 7 and 14 days,
serial dilutions of control and samples were plated on 7H10
supplemented with OADC supplement. After about 3 weeks of
incubation at 37°C, colonies were counted.
Epifluorescence and confocal fluorescence microscopy
Macrophages grown on glass coverslips were allowed to uptake
M. bovis BCG harbouring a pMN437 plasmid (live/heat killed)
or M. bovis stained with Oregon green (Molecular Probes). Cells
were fixed with 3% paraformaldehyde at room temperature for
15 min.
Lysotracker Red DND-99 (Molecular Probes) staining of acidic
organelles was carried out by adding a 1:10 000 dilution in
DMEM that was added for the last 30 min of the experiments. Cell
permeabilization, when required, was achieved with 20 min treat-
ment with 0.1% Triton X-100 (Sigma) in PBS. After 30 min block-
ing with 5% goat serum (Sigma) in 0.1% BSA/PBS, cells were
incubated for 1 h with primary antibody, followed for further
30 min by secondary antibody. For LBPA, blocking was made
with 0.1% BSA/PBS, followed by simultaneous permeabilization/
incubation with primary antibodies diluted in a 0.05% saponin
(Sigma) solution in PBS, followed for further 30 min incubation
with secondary antibodies in PBS.
Confocal microscopy images were collected using the LSM510
from Zeiss, and the percentage of colocalisation was calculated
using either the Image J software system or manually. Fluores-
cence labelling and viability of mycobacteria was performed as
described (Anes et al., 2003).
The following antibodies were used for immunofluorescence
microscopy. The mouse iNOS antibody was purchased from BD
Pharmigen, and the LBPA antibody was a kind gift from Jean
Gruenberg. The secondary antibodies used were linked to Cy3
(Molecular Probes).
Fusion assay
Analysis of phagosome–lysosome fusion was carried out using
7 nm gold particles prepared as describe before (Anes et al.,
2006). Macrophages were pulsed for 1 h with these gold par-
ticles, and washed three times with PBS. Then one of two treat-
ments was carried out: (i) chase for 1 h in complete culture
medium, infection with mycobacteria 3 h in complete medium
without antibiotics; or (ii) chase for 4 h in medium without
antibiotics. The first treatment was applied for 3 h time point, and
the second for all the others. Macrophages were fixed with 3%
PFA in PBS and processed for microscopy.
Estimation of live versus dead bacteria
Three hours, 1, 3, 5 and 7 days post infection, macrophages
were scraped, stained with trypan blue (Sigma) and counted in a
Neubauer chamber. Infected macrophages were then lysed with
1% Igepal in water. Dead mycobacteria were stained with PI as
described by Anes et al. (2006). Mycobacteria pellets were res-
suspended in PBS, and dead (red or yellow) and live (green)
bacteria were counted in a Neubauer chamber by fluorescence
microscopy.
Preparation of whole-cell extracts and
immunoblot analysis
Whole-cell extracts were prepared as previously described (Anes
et al., 2006). Equal amounts of protein were loaded on a 6%
SDS-PAGE, transferred to nitrocellulose membrane and probed
with a mouse anti-iNOS (BD Pharmigen) and mouse anti-actin
(BD Pharmigen) antibodies. Enhanced chemiluminescence
(Pierce biotechnology) was used to visualize antibody binding.
Actin was used to assess the amount of total protein in the
different membrane isolates.
Electron microscopy
Macrophages (J774.A1, HMDM) infected with M. bovis spp. as
described previously in this section were fixed with 1% glutaral-
dehyde (EM grade, Sigma) in cell culture medium without serum
for 10 min at 37°C. Cell cultures were washed several times with
200 mM Hepes pH 7.4 and incubated overnight at room tempera-
ture with 1% glutaraldehyde in 200 mM Hepes pH 7.4. Samples
were processed for cryo-sectioning as described by Tokuyasu
(1973). Negative staining of the cryo sections using ammonium
molybdate-methyl cellulaose was carried out as described by
Griffiths (1993).
After fixation, some samples were post-fixed in osmium and
uranyl acetate and embedded in epoxy resin as described pre-
viously (Bozzola et al., 1973). Thin sections were stained with
lead citrate and uranyl acetate and analysed by transmission
electron microscopy.
Modelling the intracellular transport and killing of
M. bovis BCG
A set of seven differential equations were generated in the
COPASI 4.0.20 modelling program (http://www.copasi.org) (Hoops
et al., 2006), describing the duplication, killing in early and late
compartments, transport of live and dead bacteria from early to
late compartments (= phagosome maturation), and disappear-
ance (digestion) of bacteria in early and late compartments.
Simple mass action reactions were used for the kinetics of all
steps. The same program was used to find a set of parameters
that minimize the weighted sum of square differences between
values predicted for the model and the experimental data. The
COPASI file is provided as Supplementary material.
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